Story: Armstrong had six positives from 1999 tests
By Sal Ruibal, USA TODAY
One month after winning his seventh consecutive Tour de France and retiring from professional cycling, Lance Armstrong is on the defensive over doping allegations stemming from his first Tour win in 1999.
L'Equipe, the leading sports daily newspaper in France, published a report Tuesday that said six different urine samples Armstrong provided during the 1999 Tour tested positive for the performance-enhancing drug EPO when examined in 2004 by a French lab fine-tuning EPO testing. The lab tested all the B samples from the 1999 Tour. EPO, which builds endurance, was a banned substance in 1999 but there was no approved test for it.
Of the 12 samples that returned as positive, six came from Armstrong, the story said. The lab did not identify the samples as being from Armstrong, and the testing was done with assurances that identification of the samples would be confidential and not used for doping enforcement. But L'Equipe reporters matched the samples' identification numbers in the lab report with information Armstrong released to French judicial investigators in a 2000 doping probe.
Armstrong has been at odds with French doping officials and media since his 1999 win, but he never has been linked to a positive test, a point he emphasized in his prepared rebuttal.
"The paper even admits in its own article that the science in question here is faulty and that I have no way to defend myself," Armstrong said in a statement released late Monday night. "They state: 'There will therefore be no counter-exam nor regulatory prosecutions, in a strict sense, since defendant's rights cannot be respected.' I will simply restate what I have said many times: I have never taken performance-enhancing drugs."
Based on the information published byL'Equipe, it is unlikely a legal result of positive can be determined for the 1999 urine samples from Armstrong. When blood and urine samples are processed for testing, the fluids are separated into two batches: A and B. The standard method for verifying a positive doping result requires that the A sample be tested first; if that is positive, the B sample then is tested. Positives cannot be declared unless both A and B samples are positive.
All of the 1999 Tour A samples were used up in that year's testing. Some remnants of the B samples are available, according to L'Equipe, but two B's are not legally the same as the required A and separate B samples.
Armstrong currently is entangled with several doping-related lawsuits, including a libel battle with The (London) Sunday Times for reprinting doping charges made in a book, L.A. Confidential, the Secrets of Lance Armstrong, in 2004.
What separates the most-recent charges is the journalistic credibility of L'Equipe, owned by the Amaury Sports Organisation, which also owns the Tour de France. Both businesses are housed in the same Paris office complex.
Tour director Jean-Marie Leblanc calledL'Equipe's report "very complete, very professional, very meticulous," but declined to make a final judgment until he hears from Armstrong.
Raymond Poulidor, a popular French cycling hero and three-time Tour runner-up, was clear about his position: "This is ridiculous. Why not retroactively test all the way back to 1903?"